Walter Roland B - Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA; and Department of Medicine, Division of Hematology, and Department of Epidemiology, University of Washington, Seattle, WA.

基本信息

浏览量：2

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 564 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Trem-Cel, a CRISPR/Cas9 Gene-Edited Allograft Lacking CD33, Shows Rapid Primary Engraftment with CD33-Negative Hematopoiesis in Patients with High-Risk Acute Myeloid Leukemia (AML) and Avoids Hematopoietic Toxicity during Gemtuzumab Ozogamicin (GO) Maintenance Post-Hematopoietic Cell Transplant (HCT)

John F. DiPersio,Brenda Cooper,Hyung C. Suh,Divya Koura,Léa Bernard,Nirali N. Shah,Roland B. Walter,Miguel-Angel Perales,Markus Y. Mapara,Roni Tamari,Michael Loken, Kyle Breitschwerdt,

Bloodno. 2 (2024): S237-S238

引用0浏览0引用

Relative prognostic value of flow cytometric measurable residual disease before allogeneic hematopoietic cell transplantation for adults with MDS/AML or AML

Corentin Orvain,Naveed Ali,Megan Othus,Eduardo Rodriguez-Arboli,Filippo Milano, Calvin M. Le,Brenda M. Sandmaier,Bart L. Scott,Frederick R. Appelbaum,Roland B. Walter

AMERICAN JOURNAL OF HEMATOLOGY (2024)

引用0浏览0引用

Impact of socioeconomic disparities on outcomes in adults undergoing allogeneic hematopoietic cell transplantation for acute myeloid leukemia

Daniel J. Olivieri, Megan Othus,Corentin Orvain, Eduardo Rodríguez-Arbolí,Filippo Milano, Brenda M. Sandmaier,Irum Khan, Chris Davis,Ryan S. Basom, Frederick R. Appelbaum,Roland B. Walter

Leukemiano. 4 (2024): 1-12

引用0浏览0WOSNATURE引用

Perspective on measurable residual disease testing in acute myeloid leukemia

Roland B. Walter

Leukemiano. 1 (2024): 10-13

引用0浏览0WOSNATURE引用

Time independent factors that predict relapse in adults with acute myeloid leukemia

John J. Lim,Megan Othus,Carole M. Shaw,Kathryn Russell,Anna B. Halpern,Jacob S. Appelbaum,Paul Hendrie,Roland B. Walter,Elihu H. Estey,Mary-Elizabeth M. Percival

Blood Cancer Journalno. 1 (2024): 5-5

引用0浏览0WOSNATURE引用

Preclinical Characterization of the Anti-Leukemia Activity of the CD33/CD16a/NKG2D Immune-Modulating TriNKET^® CC-96191

Margaret C. Lunn-Halbert,George S. Laszlo, Sarah Erraiss, Mark T. Orr, Heidi K. Jessup, Heather J. Thomas,Henry Chan, Mahan A. Jahromi, Jonathan Lloyd,Ann F. Cheung, Gregory P. Chang, Tanmay Dichwalkar,

Cancersno. 5 (2024): 877

引用0浏览0引用

Preclinical Characterization of the Anti-Leukemia Activity of the CD33/CD16a/NKG2D Immune-Modulating TriNKET? CC-96191